US2466420A
(en)
|
1947-11-26 |
1949-04-05 |
Eastman Kodak Co |
Ketene condensation products with aldehydes
|
US3226394A
(en)
|
1964-06-16 |
1965-12-28 |
Shulton Inc |
Pyridylethylated anthranilamides and derivatives thereof
|
CH504416A
(de)
|
1966-12-05 |
1971-03-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
|
US4551540A
(en)
|
1983-01-17 |
1985-11-05 |
Borg-Warner Chemicals, Inc. |
Substituted 2,5-dimethylpyrroles
|
US5190541A
(en)
|
1990-10-17 |
1993-03-02 |
Boston Scientific Corporation |
Surgical instrument and method
|
ES2193143T3
(es)
|
1992-03-05 |
2003-11-01 |
Univ Texas |
Uso de inmunoconjugados para la diagnosis y/o terapia de tumores vascularizaos.
|
US5474765A
(en)
|
1992-03-23 |
1995-12-12 |
Ut Sw Medical Ctr At Dallas |
Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
|
US5686472A
(en)
|
1992-10-29 |
1997-11-11 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5593992A
(en)
|
1993-07-16 |
1997-01-14 |
Smithkline Beecham Corporation |
Compounds
|
WO1996011932A1
(en)
|
1994-10-14 |
1996-04-25 |
Smithkline Beecham Plc |
2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
|
WO1996032907A1
(en)
|
1995-04-19 |
1996-10-24 |
Schneider (Usa) Inc. |
Drug release coated stent
|
US6117432A
(en)
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
TW349948B
(en)
|
1995-10-31 |
1999-01-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 2-quinolone derivatives
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
DE69620445T2
(de)
|
1995-12-08 |
2002-12-12 |
Janssen Pharmaceutica Nv |
(imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
|
US5874442A
(en)
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US5702390A
(en)
|
1996-03-12 |
1997-12-30 |
Ethicon Endo-Surgery, Inc. |
Bioplar cutting and coagulation instrument
|
CA2262676A1
(en)
|
1996-08-09 |
1998-02-19 |
Merck & Co., Inc. |
Stereoselective deoxygenation reaction
|
DE69725604T2
(de)
|
1996-12-20 |
2005-03-03 |
Sergazy Mynzhasarovich Adekenov |
VERFAHREN UND GERÄT ZUR HERSTELLUNG VPM LYOPHILISIERTEM 1ß, 10ß-EPOXY-13-DIMETHYLAMINO-GUAIA-3(4)-EN-6,12-OLID-HYDROCHLORID
|
UA59384C2
(uk)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
TW591030B
(en)
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
PL190944B1
(pl)
|
1997-04-25 |
2006-02-28 |
Janssen Pharmaceutica Nv |
Pochodna chinazolinonu i sposób jej wytwarzania oraz kompozycja farmaceutyczna i sposób jej wytwarzania
|
TW491872B
(en)
|
1997-05-27 |
2002-06-21 |
Ciba Sc Holding Ag |
Block oligomers containing l-hydrocarbyloxy-2,2,6,6-tetramethyl-4- piperidyl groups as stabilizers for lower polyolefin
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
HU228537B1
(en)
|
1998-03-05 |
2013-03-28 |
Formula One Man Ltd |
Data communication system
|
US6303654B1
(en)
|
1998-03-12 |
2001-10-16 |
Wisconsin Alumni Research Foundation |
Acyclic monoterpenoid derivatives
|
WO2000001691A1
(en)
|
1998-07-01 |
2000-01-13 |
Merck & Co., Inc. |
Process for making farnesyl-protein transferase inhibitors
|
CA2336848A1
(en)
|
1998-07-10 |
2000-01-20 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
WO2000012498A1
(en)
|
1998-08-27 |
2000-03-09 |
Pfizer Products Inc. |
Quinolin-2-one derivatives useful as anticancer agents
|
NZ509372A
(en)
|
1998-08-27 |
2003-08-29 |
Pfizer Prod Inc |
Substituted quinolin-2-one derivatives, pharmaceuticals thereof and their use for treating abnormal cell growth (e.g. cancer)
|
GB9824579D0
(en)
|
1998-11-10 |
1999-01-06 |
Novartis Ag |
Organic compounds
|
DE69907964T2
(de)
|
1998-12-23 |
2004-02-19 |
Janssen Pharmaceutica N.V. |
1,2-annelierte chinolinderivate
|
JP4876239B2
(ja)
|
1999-01-11 |
2012-02-15 |
プリンストン ユニバーシティー |
標的確認のための高親和性阻害剤およびその使用
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
MXPA01010292A
(es)
|
1999-04-15 |
2002-10-23 |
Squibb Bristol Myers Co |
Inhibidores ciclicos de la proteina tirosina cinasa.
|
KR100816572B1
(ko)
|
1999-04-28 |
2008-03-24 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
항-vegf 항체 및 이를 포함하는 약제학적 조성물
|
US6346625B1
(en)
|
1999-06-23 |
2002-02-12 |
Astrazeneca Ab |
Protein kinase inhibitors
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
WO2001047921A1
(en)
|
1999-12-28 |
2001-07-05 |
Pharmacopeia, Inc. |
Pyrimidine and triazine kinase inhibitors
|
FR2803592A1
(fr)
|
2000-01-06 |
2001-07-13 |
Aventis Cropscience Sa |
Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
|
US6558385B1
(en)
|
2000-09-22 |
2003-05-06 |
Tissuelink Medical, Inc. |
Fluid-assisted medical device
|
US6692491B1
(en)
|
2000-03-24 |
2004-02-17 |
Scimed Life Systems, Inc. |
Surgical methods and apparatus for positioning a diagnostic or therapeutic element around one or more pulmonary veins or other body structures
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
ATE303998T1
(de)
|
2000-10-17 |
2005-09-15 |
Merck & Co Inc |
Oral aktive salze mit tyrosinkinaseaktivität
|
US6958243B2
(en)
*
|
2000-12-14 |
2005-10-25 |
Biotage Ab |
Organic reactions with CO generating materials
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
WO2003024969A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
WO2003024931A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
TWI259081B
(en)
|
2001-10-26 |
2006-08-01 |
Sugen Inc |
Treatment of acute myeloid leukemia with indolinone compounds
|
RU2337692C3
(ru)
|
2001-10-30 |
2020-11-09 |
Новартис Аг |
Производные стауроспорина в качестве ингибиторов активности рецепторной тирозинкиназы flt3
|
IL162203A0
(en)
|
2001-12-27 |
2005-11-20 |
Theravance Inc |
Indolinone derivatives useful as protein inase inhibitors
|
CA2486183C
(en)
|
2002-05-23 |
2012-01-10 |
Cytopia Pty Ltd. |
Protein kinase inhibitors
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
WO2004016597A2
(en)
|
2002-08-14 |
2004-02-26 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
AU2003288899B2
(en)
|
2002-08-23 |
2009-09-03 |
Novartis Vaccines And Diagnostics, Inc. |
Benzimidazole quinolinones and uses thereof
|
WO2004022525A1
(en)
|
2002-09-05 |
2004-03-18 |
Neurosearch A/S |
Amide derivatives and their use as chloride channel blockers
|
JP4560483B2
(ja)
|
2002-10-03 |
2010-10-13 |
ターゲジェン インコーポレーティッド |
血管静態化物質およびそれらの使用法
|
US20080207617A1
(en)
|
2002-10-29 |
2008-08-28 |
Kirin Beer Kabushiki Kaisha |
Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same
|
BR0316229A
(pt)
|
2002-11-13 |
2005-10-04 |
Chiron Corp |
Métodos de tratamento de câncer e métodos relacionados
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
WO2004058749A1
(en)
|
2002-12-18 |
2004-07-15 |
Vertex Pharmaceuticals Incorporated |
Benzisoxazole derivatives useful as inhibitors of protein kinases
|
TW200500362A
(en)
|
2003-04-09 |
2005-01-01 |
Japan Tobacco Inc |
5-membered heteroaromatic ring compound and pharmaceutical use thereof
|
US7790724B2
(en)
|
2003-04-25 |
2010-09-07 |
Janssen Pharmaceutica N.V. |
c-fms kinase inhibitors
|
JP2007525460A
(ja)
|
2003-04-25 |
2007-09-06 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
c−fmsキナーゼ阻害剤
|
US7427683B2
(en)
*
|
2003-04-25 |
2008-09-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
c-fms kinase inhibitors
|
US20050113566A1
(en)
|
2003-04-25 |
2005-05-26 |
Player Mark R. |
Inhibitors of C-FMS kinase
|
MXPA06001094A
(es)
|
2003-07-28 |
2006-04-11 |
Smithkline Beecham Corp |
Compuestos quimicos.
|
CA2542909C
(en)
|
2003-10-23 |
2012-07-10 |
Ab Science |
2-aminoaryloxazole compounds as tyrosine kinase inhibitors
|
GB0326601D0
(en)
|
2003-11-14 |
2003-12-17 |
Novartis Ag |
Organic compounds
|
WO2005073225A1
(en)
|
2004-01-30 |
2005-08-11 |
Ab Science |
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
|
US7662837B2
(en)
|
2004-10-22 |
2010-02-16 |
Janssen Pharmaceutica N.V. |
Inhibitors of c-fms kinase
|
CN101437514B
(zh)
|
2004-10-22 |
2012-04-25 |
詹森药业有限公司 |
C-fms激酶抑制剂
|
WO2006047504A1
(en)
|
2004-10-22 |
2006-05-04 |
Janssen Pharmaceutica, N.V. |
Aromatic amides as inhibitors of c-fms kinase
|
US7645755B2
(en)
|
2004-10-22 |
2010-01-12 |
Janssen Pharmaceutical N.V. |
Inhibitors of c-fms kinase
|
US20060281771A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
|
US20060281755A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
US20060281700A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
US20060281788A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
|
US20060281769A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
|
NZ595182A
(en)
|
2005-10-18 |
2012-12-21 |
Janssen Pharmaceutica Nv |
Pharmaceutical uses of 4-cyano-1H-imidazole-2-carboxylic acid { 2-cyclohex-1-enyl-4-[1-(2-dimethylamino-acetyl)-piperidin-4-yl]-phenyl} -amide
|
ES2581600T3
(es)
|
2006-04-20 |
2016-09-06 |
Janssen Pharmaceutica, N.V. |
Inhibidores de quinasa c-fms
|
WO2007124316A1
(en)
|
2006-04-20 |
2007-11-01 |
Janssen Pharmaceutica N.V. |
Heterocyclic compounds as inhibitors of c-fms kinase
|
RU2475483C2
(ru)
|
2006-04-20 |
2013-02-20 |
Янссен Фармацевтика Н.В. |
Ингибиторы с-fms киназы
|
US8697716B2
(en)
|
2006-04-20 |
2014-04-15 |
Janssen Pharmaceutica Nv |
Method of inhibiting C-KIT kinase
|
US20100298314A1
(en)
*
|
2006-12-20 |
2010-11-25 |
Schering Corporation |
Novel jnk inhibitors
|
WO2008138184A1
(fr)
*
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
JO3240B1
(ar)
|
2007-10-17 |
2018-03-08 |
Janssen Pharmaceutica Nv |
c-fms مثبطات كيناز
|
WO2009058968A2
(en)
|
2007-10-31 |
2009-05-07 |
Janssen Pharmaceutica N.V. |
Biomarker for assessing response to fms treatment
|
AU2009334997A1
(en)
*
|
2008-12-30 |
2011-08-04 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as Raf kinase inhibitors
|
JP2011026305A
(ja)
*
|
2009-06-24 |
2011-02-10 |
Daiichi Sankyo Co Ltd |
イミダゾールカルボニル化合物を含有する医薬組成物
|
ES2444779T3
(es)
*
|
2009-09-28 |
2014-02-26 |
F. Hoffmann-La Roche Ag |
Compuestos de benzoxazepina inhibidores de la PI3K y su utilización en el tratamiento de cáncer
|
US9227971B2
(en)
*
|
2010-01-19 |
2016-01-05 |
Merck Sharp & Dohme Corp. |
Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
|
IN2015DN00659A
(uk)
*
|
2012-08-07 |
2015-06-26 |
Janssen Pharmaceutica Nv |
|